Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity × Ketorolac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Pain, Postoperative 3 Pain 3 Agnosia 3 Inflammation 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Thyroid Nodule 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Ileus 1 Goiter 1 Fallopian Tube Neoplasms 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Exercise 21 Metformin 18 Methods 7 Diet Therapy 7 Diet 7 Tirzepatide 6 Resistance Training 6 Nutrition Assessment 6 Early Intervention, Educational 6 Counseling 6 Caloric Restriction 6 Exenatide 5 Educational Status 4 Docosahexaenoic Acids 4 Diet, Mediterranean 4 semaglutide 3 Vitamin D 3 Standard of Care 3 Liraglutide 3 Dexamethasone 3 Yoga 2 Therapeutics 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Specimen Handling 2 Ovidrel 2 Nutritional Status 2 Naltrexone 2 Mindfulness-Based Stress Reduction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡